Literature DB >> 16973441

JNK2 is a positive regulator of the cJun transcription factor.

Anja Jaeschke1, Maria Karasarides, Juan-Jose Ventura, Anka Ehrhardt, Chao Zhang, Richard A Flavell, Kevan M Shokat, Roger J Davis.   

Abstract

The cJun NH(2)-terminal kinase (JNK) signal transduction pathway is established to be an important mechanism of regulation of the cJun transcription factor. Studies of Jnk1(-/-) and Jnk2(-/-) mice suggest that the JNK1 and JNK2 isoforms have opposite effects on cJun expression and proliferation. Here, we demonstrate, using a chemical genetic approach, that both JNK1 and JNK2 are positive regulators of these processes. We show that competition between JNK1 and JNK2 contributes to the opposite phenotypes caused by JNK1 and JNK2 deficiency. Our analysis illustrates the power of a chemical genetics approach for the analysis of signal transduction pathways and also highlights the limitations of single gene knockout strategies for the analysis of signaling pathways that are formed by a network of interacting proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16973441     DOI: 10.1016/j.molcel.2006.07.028

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  86 in total

1.  Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.

Authors:  Tessi Sherrin; Thomas Blank; Cathrin Hippel; Martin Rayner; Roger J Davis; Cedomir Todorovic
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

2.  Distinct roles of c-Jun N-terminal kinase isoforms in neurite initiation and elongation during axonal regeneration.

Authors:  Monia Barnat; Hervé Enslen; Friedrich Propst; Roger J Davis; Sylvia Soares; Fatiha Nothias
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 3.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

4.  JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Authors:  Katja Denninger; Susanne Rasmussen; Jeppe Madura Larsen; Catrine Orskov; Steen Seier Poulsen; Poul Sørensen; Jan Pravsgaard Christensen; Harald Illges; Niels Odum; Tord Labuda
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

5.  Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation.

Authors:  Hiroaki Inaba; Hideyuki Sugita; Masae Kuboniwa; Soichi Iwai; Masakazu Hamada; Takeshi Noda; Ichijiro Morisaki; Richard J Lamont; Atsuo Amano
Journal:  Cell Microbiol       Date:  2013-09-19       Impact factor: 3.715

6.  Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.

Authors:  Cristina Cellurale; Guadalupe Sabio; Norman J Kennedy; Madhumita Das; Marissa Barlow; Peter Sandy; Tyler Jacks; Roger J Davis
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

7.  Tissue-specific PKA inhibition using a chemical genetic approach and its application to studies on sperm capacitation.

Authors:  Daniel J Morgan; Michael Weisenhaus; Sara Shum; Thomas Su; Ruimao Zheng; Chao Zhang; Kevan M Shokat; Bertil Hille; Donner F Babcock; G Stanley McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

8.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

9.  Structure and substrate recruitment of the human spindle checkpoint kinase Bub1.

Authors:  Jungseog Kang; Maojun Yang; Bing Li; Wei Qi; Chao Zhang; Kevan M Shokat; Diana R Tomchick; Mischa Machius; Hongtao Yu
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

10.  c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.

Authors:  J L Varona-Santos; A Pileggi; R D Molano; N Y Sanabria; A Ijaz; M Atsushi; H Ichii; R L Pastori; L Inverardi; C Ricordi; A Fornoni
Journal:  Diabetologia       Date:  2008-10-14       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.